Skip to content
← Back to this collection

PUBLICATIONS · 34000246

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2021 Jun
First author
Stratigos AJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2021 Jul;18(7):400. doi: 10.1038/s41571-021-00528-7.
    note
    Source null
    related pmid
    34035503
    relationship
    Comment in

Authors and identifiers

  1. name
    Stratigos AJ
    type
    Author
  2. name
    Sekulic A
    type
    Author
  3. name
    Peris K
    type
    Author
  4. name
    Bechter O
    type
    Author
  5. name
    Prey S
    type
    Author
  6. name
    Kaatz M
    type
    Author
  7. name
    Lewis KD
    type
    Author
  8. name
    Basset-Seguin N
    type
    Author
  9. name
    Chang ALS
    type
    Author
  10. name
    Dalle S
    type
    Author
  11. name
    Orland AF
    type
    Author
  12. name
    Licitra L
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Stratigos AJ
    type
    Author
  2. name
    Sekulic A
    type
    Author
  3. name
    Peris K
    type
    Author
  4. name
    Bechter O
    type
    Author
  5. name
    Prey S
    type
    Author
  6. name
    Kaatz M
    type
    Author
  7. name
    Lewis KD
    type
    Author
  8. name
    Basset-Seguin N
    type
    Author
  9. name
    Chang ALS
    type
    Author
  10. name
    Dalle S
    type
    Author
  11. name
    Orland AF
    type
    Author
  12. name
    Licitra L
    type
    Author
bibliography ids
  1. nci-bib-a9eb2a9d10f26e97ffe5c685
book metadata
content sha256
d61a8837c1e579313b4365b0e2fa28112aa95586b19bd23f396cc8ec046a6af9
document type
citation
dois
  1. 10.1016/S1470-2045(21)00126-1
electronic publication date
display
2021 May 14
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34000246
immutable id
pubmed:34000246@d61a8837c1e579313b4365b0e2fa28112aa95586b19bd23f396cc8ec046a6af9
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
6
name
The Lancet. Oncology
nlm unique id
100957246
pages
848-857
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2021 Jul;18(7):400. doi: 10.1038/s41571-021-00528-7.
    note
    Source null
    related pmid
    34035503
    relationship
    Comment in
outcomes validated
false
pmid
34000246
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
53bc92411ba927e214d95e236f6e00ee3214fd6a8aa6baa547577024120cd9fd
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Jun
precision
month
year
2021
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34000246/
title
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.

Preserved source evidence · Not medical advice